Summary

Drug Discovery Outsourcing Market: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Drug Discovery Outsourcing offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Workflow:

• Target Identification & Screening
• Target Validation & Functional Informatics
• Lead Identification & Candidate Optimization
• Preclinical Development
• Other Associated Workflow

By Therapeutics Area:

• Respiratory system
• Pain and Anesthesia
• Oncology
• Ophthalmology
• Hematology
• Cardiovascular
• Endocrine
• Gastrointestinal
• Immunomodulation
• Anti-infective
• Central Nervous System
• Dermatology
• Genitourinary System

By Drug Type:

• Small Molecules
• Large Molecules (Biopharmaceuticals)

By Service Type:

• Chemistry Services
• Biology Services

By End-user:

• Pharmaceutical & Biotechnology companies
• Academic Institutes
• Others

By Regions:

• North America
• Europe
• Japan
• Asia Pacific Excluding Japan
• Latin America
• MEA

Report Chapters

Executive Summary

The executive summary of the Drug Discovery Outsourcing Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Vehicle Radar Test System.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Drug Discovery Outsourcing Market in this chapter, which will help to understand basic information about Vehicle Radar Test System. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Drug Discovery Outsourcing Market report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Workflow processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Drug Discovery Outsourcing Market Demand Analysis 2018-2022 and Forecast, 2023-2033

The chapter include historical market value (US$ 3.50 billion) analysis (2018-2022) and current and future market value (US$ 3.75 billion) and volume (7.2%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Drug Discovery Outsourcing Market - Pricing Analysis

Based on By Workflow, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Workflow

Based on By Workflow, Drug Discovery Outsourcing Market is segmented into Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimization, Preclinical Development, Other Associated Workflow. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Workflow.

Chapter 06 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Therapeutics Area

Based on By Therapeutics Area, Drug Discovery Outsourcing Market is segmented into Respiratory system, Pain and Anesthesia, Oncology, Ophthalmology, Hematology, Cardiovascular, Endocrine, Gastrointestinal, Immunomodulation, Anti-infective, Central Nervous System, Dermatology, Genitourinary System. This section also offers market attractiveness analysis based on By Therapeutics Area. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Therapeutics Area.

Chapter 07 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Drug Type

Based on By Drug Type, Drug Discovery Outsourcing Market is segmented into Small Molecules, Large Molecules (Biopharmaceuticals). This section also offers market attractiveness analysis based on By Drug Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Drug Type.

Chapter 08 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Service Type

Based on By Service Type, Drug Discovery Outsourcing Market is segmented into Chemistry Services, Biology Services. This section also offers market attractiveness analysis based on By Service Type. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Service Type.

Chapter 09 - Global Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By End-user

Based on By End-user, Drug Discovery Outsourcing Market is segmented into Pharmaceutical & Biotechnology companies, Academic Institutes, Others. This section also offers market attractiveness analysis based on By End-user. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End-user.

Chapter 10 - Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033, By Regions

Based on By Regions, Drug Discovery Outsourcing Market is segmented into North America, Latin America, Europe, Japan, Asia Pacific Excluding Japan and MEA. This section also offers market attractiveness analysis based on By Regions. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Regions.

Chapter 11 - North America Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of the Vehicle Radar Test System in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 12 - Latin America Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the Latin America region.

Chapter 13 - Europe Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market.

Chapter 14 - East Asia Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market.

Chapter 15 - South Asia Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market.

Chapter 16 - Middle East and Africa Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Vehicle Radar Test System in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Drug Discovery Outsourcing Market in the regional market.

Chapter 17 - Key Countries Drug Discovery Outsourcing Market Analysis 2018-2022 and Forecast 2023-2033

This chapter offers insights into how the Drug Discovery Outsourcing Market is expected to grow in major countries globally.

Chapter 18 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 19 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Workflow portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Albany Molecular Research Inc., EVOTEC, Laboratory Corporation of America Holdings, GenScript, Pharmaceutical Product Development, LLC, Charles River, WuXi AppTec, Merck & Co., Inc., Thermo Fisher Scientific Inc., Dalton Pharma Services, Oncodesign, Jubilant Biosys, DiscoverX Corp., QIAGEN, Eurofins SE, Syngene International Limited, Dr. Reddy Laboratories Ltd., Pharmaron Beijing Co., Ltd., TCG Lifesciences Pvt Ltd., Domainex Ltd.

Chapter 20 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Vehicle Radar Test System report.

Chapter 21 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Drug Discovery Outsourcing Market.

ページTOPに戻る

Table of Contents

1. Executive Summary | Drug Discovery Outsourcing Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Investment Feasibility Matrix

    3.5. PESTLE and Porter’s Analysis

    3.6. Regulatory Landscape

        3.6.1. By Key Regions

        3.6.2. By Key Countries

    3.7. Regional Parent Market Outlook

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Workflow

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) Analysis By Workflow, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Workflow, 2023 to 2033

        5.3.1. Target Identification & Screening

        5.3.2. Target Validation & Functional Informatics

        5.3.3. Lead Identification & Candidate Optimization

        5.3.4. Preclinical Development

        5.3.5. Other Associated Workflow

    5.4. Y-o-Y Growth Trend Analysis By Workflow, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Workflow, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Therapeutics Area

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) Analysis By Therapeutics Area, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Therapeutics Area, 2023 to 2033

        6.3.1. Respiratory system

        6.3.2. Pain and Anaesthesia

        6.3.3. Oncology

        6.3.4. Ophthalmology

        6.3.5. Haematology

        6.3.6. Cardiovascular

        6.3.7. Endocrine

        6.3.8. Gastrointestinal

        6.3.9. Immunomodulation

        6.3.10. Dermatology

        6.3.11. Central Nervous System

        6.3.12. Genitourinary System

    6.4. Y-o-Y Growth Trend Analysis By Therapeutics Area, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Therapeutics Area, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Drug Type

    7.1. Introduction / Key Findings

    7.2. Historical Market Size Value (US$ Million) Analysis By Drug Type, 2018 to 2022

    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Drug Type, 2023 to 2033

        7.3.1. Small Molecules

        7.3.2. Large Molecules

    7.4. Y-o-Y Growth Trend Analysis By Drug Type, 2018 to 2022

    7.5. Absolute $ Opportunity Analysis By Drug Type, 2023 to 2033

8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User

    8.1. Introduction / Key Findings

    8.2. Historical Market Size Value (US$ Million) Analysis By End User, 2018 to 2022

    8.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User, 2023 to 2033

        8.3.1. Pharmaceutical and Biotechnology companies

        8.3.2. Academic Institutes

    8.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022

    8.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    9.1. Introduction

    9.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022

    9.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033

        9.3.1. North America

        9.3.2. Latin America

        9.3.3. Europe

        9.3.4. South Asia

        9.3.5. East Asia

        9.3.6. Oceania

        9.3.7. MEA

    9.4. Market Attractiveness Analysis By Region

10. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. USA

            10.2.1.2. Canada

        10.2.2. By Workflow

        10.2.3. By Therapeutics Area

        10.2.4. By Drug Type

        10.2.5. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Workflow

        10.3.3. By Therapeutics Area

        10.3.4. By Drug Type

        10.3.5. By End User

    10.4. Key Takeaways

11. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Brazil

            11.2.1.2. Mexico

            11.2.1.3. Rest of Latin America

        11.2.2. By Workflow

        11.2.3. By Therapeutics Area

        11.2.4. By Drug Type

        11.2.5. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Workflow

        11.3.3. By Therapeutics Area

        11.3.4. By Drug Type

        11.3.5. By End User

    11.4. Key Takeaways

12. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Germany

            12.2.1.2. United kingdom

            12.2.1.3. France

            12.2.1.4. Spain

            12.2.1.5. Italy

            12.2.1.6. Rest of Europe

        12.2.2. By Workflow

        12.2.3. By Therapeutics Area

        12.2.4. By Drug Type

        12.2.5. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Workflow

        12.3.3. By Therapeutics Area

        12.3.4. By Drug Type

        12.3.5. By End User

    12.4. Key Takeaways

13. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. India

            13.2.1.2. Malaysia

            13.2.1.3. Singapore

            13.2.1.4. Thailand

            13.2.1.5. Rest of South Asia

        13.2.2. By Workflow

        13.2.3. By Therapeutics Area

        13.2.4. By Drug Type

        13.2.5. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Workflow

        13.3.3. By Therapeutics Area

        13.3.4. By Drug Type

        13.3.5. By End User

    13.4. Key Takeaways

14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. China

            14.2.1.2. Japan

            14.2.1.3. South Korea

        14.2.2. By Workflow

        14.2.3. By Therapeutics Area

        14.2.4. By Drug Type

        14.2.5. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Workflow

        14.3.3. By Therapeutics Area

        14.3.4. By Drug Type

        14.3.5. By End User

    14.4. Key Takeaways

15. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        15.2.1. By Country

            15.2.1.1. Australia

            15.2.1.2. New Zealand

        15.2.2. By Workflow

        15.2.3. By Therapeutics Area

        15.2.4. By Drug Type

        15.2.5. By End User

    15.3. Market Attractiveness Analysis

        15.3.1. By Country

        15.3.2. By Workflow

        15.3.3. By Therapeutics Area

        15.3.4. By Drug Type

        15.3.5. By End User

    15.4. Key Takeaways

16. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    16.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022

    16.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033

        16.2.1. By Country

            16.2.1.1. GCC Countries

            16.2.1.2. South Africa

            16.2.1.3. Israel

            16.2.1.4. Rest of MEA

        16.2.2. By Workflow

        16.2.3. By Therapeutics Area

        16.2.4. By Drug Type

        16.2.5. By End User

    16.3. Market Attractiveness Analysis

        16.3.1. By Country

        16.3.2. By Workflow

        16.3.3. By Therapeutics Area

        16.3.4. By Drug Type

        16.3.5. By End User

    16.4. Key Takeaways

17. Key Countries Market Analysis

    17.1. USA

        17.1.1. Pricing Analysis

        17.1.2. Market Share Analysis, 2022

            17.1.2.1. By Workflow

            17.1.2.2. By Therapeutics Area

            17.1.2.3. By Drug Type

            17.1.2.4. By End User

    17.2. Canada

        17.2.1. Pricing Analysis

        17.2.2. Market Share Analysis, 2022

            17.2.2.1. By Workflow

            17.2.2.2. By Therapeutics Area

            17.2.2.3. By Drug Type

            17.2.2.4. By End User

    17.3. Brazil

        17.3.1. Pricing Analysis

        17.3.2. Market Share Analysis, 2022

            17.3.2.1. By Workflow

            17.3.2.2. By Therapeutics Area

            17.3.2.3. By Drug Type

            17.3.2.4. By End User

    17.4. Mexico

        17.4.1. Pricing Analysis

        17.4.2. Market Share Analysis, 2022

            17.4.2.1. By Workflow

            17.4.2.2. By Therapeutics Area

            17.4.2.3. By Drug Type

            17.4.2.4. By End User

    17.5. Germany

        17.5.1. Pricing Analysis

        17.5.2. Market Share Analysis, 2022

            17.5.2.1. By Workflow

            17.5.2.2. By Therapeutics Area

            17.5.2.3. By Drug Type

            17.5.2.4. By End User

    17.6. United kingdom

        17.6.1. Pricing Analysis

        17.6.2. Market Share Analysis, 2022

            17.6.2.1. By Workflow

            17.6.2.2. By Therapeutics Area

            17.6.2.3. By Drug Type

            17.6.2.4. By End User

    17.7. France

        17.7.1. Pricing Analysis

        17.7.2. Market Share Analysis, 2022

            17.7.2.1. By Workflow

            17.7.2.2. By Therapeutics Area

            17.7.2.3. By Drug Type

            17.7.2.4. By End User

    17.8. Spain

        17.8.1. Pricing Analysis

        17.8.2. Market Share Analysis, 2022

            17.8.2.1. By Workflow

            17.8.2.2. By Therapeutics Area

            17.8.2.3. By Drug Type

            17.8.2.4. By End User

    17.9. Italy

        17.9.1. Pricing Analysis

        17.9.2. Market Share Analysis, 2022

            17.9.2.1. By Workflow

            17.9.2.2. By Therapeutics Area

            17.9.2.3. By Drug Type

            17.9.2.4. By End User

    17.10. India

        17.10.1. Pricing Analysis

        17.10.2. Market Share Analysis, 2022

            17.10.2.1. By Workflow

            17.10.2.2. By Therapeutics Area

            17.10.2.3. By Drug Type

            17.10.2.4. By End User

    17.11. Malaysia

        17.11.1. Pricing Analysis

        17.11.2. Market Share Analysis, 2022

            17.11.2.1. By Workflow

            17.11.2.2. By Therapeutics Area

            17.11.2.3. By Drug Type

            17.11.2.4. By End User

    17.12. Singapore

        17.12.1. Pricing Analysis

        17.12.2. Market Share Analysis, 2022

            17.12.2.1. By Workflow

            17.12.2.2. By Therapeutics Area

            17.12.2.3. By Drug Type

            17.12.2.4. By End User

    17.13. Thailand

        17.13.1. Pricing Analysis

        17.13.2. Market Share Analysis, 2022

            17.13.2.1. By Workflow

            17.13.2.2. By Therapeutics Area

            17.13.2.3. By Drug Type

            17.13.2.4. By End User

    17.14. China

        17.14.1. Pricing Analysis

        17.14.2. Market Share Analysis, 2022

            17.14.2.1. By Workflow

            17.14.2.2. By Therapeutics Area

            17.14.2.3. By Drug Type

            17.14.2.4. By End User

    17.15. Japan

        17.15.1. Pricing Analysis

        17.15.2. Market Share Analysis, 2022

            17.15.2.1. By Workflow

            17.15.2.2. By Therapeutics Area

            17.15.2.3. By Drug Type

            17.15.2.4. By End User

    17.16. South Korea

        17.16.1. Pricing Analysis

        17.16.2. Market Share Analysis, 2022

            17.16.2.1. By Workflow

            17.16.2.2. By Therapeutics Area

            17.16.2.3. By Drug Type

            17.16.2.4. By End User

    17.17. Australia

        17.17.1. Pricing Analysis

        17.17.2. Market Share Analysis, 2022

            17.17.2.1. By Workflow

            17.17.2.2. By Therapeutics Area

            17.17.2.3. By Drug Type

            17.17.2.4. By End User

    17.18. New Zealand

        17.18.1. Pricing Analysis

        17.18.2. Market Share Analysis, 2022

            17.18.2.1. By Workflow

            17.18.2.2. By Therapeutics Area

            17.18.2.3. By Drug Type

            17.18.2.4. By End User

    17.19. GCC Countries

        17.19.1. Pricing Analysis

        17.19.2. Market Share Analysis, 2022

            17.19.2.1. By Workflow

            17.19.2.2. By Therapeutics Area

            17.19.2.3. By Drug Type

            17.19.2.4. By End User

    17.20. South Africa

        17.20.1. Pricing Analysis

        17.20.2. Market Share Analysis, 2022

            17.20.2.1. By Workflow

            17.20.2.2. By Therapeutics Area

            17.20.2.3. By Drug Type

            17.20.2.4. By End User

    17.21. Israel

        17.21.1. Pricing Analysis

        17.21.2. Market Share Analysis, 2022

            17.21.2.1. By Workflow

            17.21.2.2. By Therapeutics Area

            17.21.2.3. By Drug Type

            17.21.2.4. By End User

18. Market Structure Analysis

    18.1. Competition Dashboard

    18.2. Competition Benchmarking

    18.3. Market Share Analysis of Top Players

        18.3.1. By Regional

        18.3.2. By Workflow

        18.3.3. By Therapeutics Area

        18.3.4. By Drug Type

        18.3.5. By End User

19. Competition Analysis

    19.1. Competition Deep Dive

        19.1.1. Albany Molecular Research Inc.

            19.1.1.1. Overview

            19.1.1.2. Product Portfolio

            19.1.1.3. Profitability by Market Segments

            19.1.1.4. Sales Footprint

            19.1.1.5. Strategy Overview

                19.1.1.5.1. Marketing Strategy

        19.1.2. EVOTEC

            19.1.2.1. Overview

            19.1.2.2. Product Portfolio

            19.1.2.3. Profitability by Market Segments

            19.1.2.4. Sales Footprint

            19.1.2.5. Strategy Overview

                19.1.2.5.1. Marketing Strategy

        19.1.3. Laboratory Corporation of America Holdings

            19.1.3.1. Overview

            19.1.3.2. Product Portfolio

            19.1.3.3. Profitability by Market Segments

            19.1.3.4. Sales Footprint

            19.1.3.5. Strategy Overview

                19.1.3.5.1. Marketing Strategy

        19.1.4. GenScript

            19.1.4.1. Overview

            19.1.4.2. Product Portfolio

            19.1.4.3. Profitability by Market Segments

            19.1.4.4. Sales Footprint

            19.1.4.5. Strategy Overview

                19.1.4.5.1. Marketing Strategy

        19.1.5. Pharmaceutical Product Development, LLC

            19.1.5.1. Overview

            19.1.5.2. Product Portfolio

            19.1.5.3. Profitability by Market Segments

            19.1.5.4. Sales Footprint

            19.1.5.5. Strategy Overview

                19.1.5.5.1. Marketing Strategy

        19.1.6. Merck & Co., Inc.

            19.1.6.1. Overview

            19.1.6.2. Product Portfolio

            19.1.6.3. Profitability by Market Segments

            19.1.6.4. Sales Footprint

            19.1.6.5. Strategy Overview

                19.1.6.5.1. Marketing Strategy

        19.1.7. Thermo Fisher Scientific Inc.

            19.1.7.1. Overview

            19.1.7.2. Product Portfolio

            19.1.7.3. Profitability by Market Segments

            19.1.7.4. Sales Footprint

            19.1.7.5. Strategy Overview

                19.1.7.5.1. Marketing Strategy

        19.1.8. Dalton Pharma Services

            19.1.8.1. Overview

            19.1.8.2. Product Portfolio

            19.1.8.3. Profitability by Market Segments

            19.1.8.4. Sales Footprint

            19.1.8.5. Strategy Overview

                19.1.8.5.1. Marketing Strategy

        19.1.9. Dr. Reddy Laboratories Ltd.

            19.1.9.1. Overview

            19.1.9.2. Product Portfolio

            19.1.9.3. Profitability by Market Segments

            19.1.9.4. Sales Footprint

            19.1.9.5. Strategy Overview

                19.1.9.5.1. Marketing Strategy

        19.1.10. Pharmaron Beijing Co., Ltd.

            19.1.10.1. Overview

            19.1.10.2. Product Portfolio

            19.1.10.3. Profitability by Market Segments

            19.1.10.4. Sales Footprint

            19.1.10.5. Strategy Overview

                19.1.10.5.1. Marketing Strategy

        19.1.11. TCG Lifesciences Pvt Ltd.

            19.1.11.1. Overview

            19.1.11.2. Product Portfolio

            19.1.11.3. Profitability by Market Segments

            19.1.11.4. Sales Footprint

            19.1.11.5. Strategy Overview

                19.1.11.5.1. Marketing Strategy

        19.1.12. Domainex Ltd.

            19.1.12.1. Overview

            19.1.12.2. Product Portfolio

            19.1.12.3. Profitability by Market Segments

            19.1.12.4. Sales Footprint

            19.1.12.5. Strategy Overview

                19.1.12.5.1. Marketing Strategy

        19.1.13. Eurofins SE

            19.1.13.1. Overview

            19.1.13.2. Product Portfolio

            19.1.13.3. Profitability by Market Segments

            19.1.13.4. Sales Footprint

            19.1.13.5. Strategy Overview

                19.1.13.5.1. Marketing Strategy

        19.1.14. Syngene International Limited

            19.1.14.1. Overview

            19.1.14.2. Product Portfolio

            19.1.14.3. Profitability by Market Segments

            19.1.14.4. Sales Footprint

            19.1.14.5. Strategy Overview

                19.1.14.5.1. Marketing Strategy

20. Assumptions & Acronyms Used

21. Research Methodology